Virvio

Virvio is a preclinical biotherapeutic discovery company and a world leader in the field of computationally designed protein scaffolds, known as "mini-binders." Our platform generates leads with antibody-like affinity and specificity, while also possessing the ultra-stability and manufacturability of small molecule drugs. Mini-binders are small, structured proteins specifically designed to meet molecular target and indication requirements.